[1]
Baughman, R.P. et al. 2025. WASOG Clinical Trial Endpoint Task Force: Executive Summary. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 42, 3 (Sep. 2025), 17859. DOI:https://doi.org/10.36141/svdld.v42i3.17859.